{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-051362","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2025-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.128709+00:00","generated_at":"2026-05-23T19:42:54.834817+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"James Treace to retire from board; CEO John Treace appointed chairman effective May 20, 2025","bullets":["James T. Treace to retire from board at 2025 annual meeting (expected May 20, 2025); departure not related to any disagreement.","Board appoints CEO & Founder John T. Treace as Chairman, effective immediately after the 2025 annual meeting.","Board size decreases from nine to eight directors upon James Treace's retirement.","Lead independent director Richard W. Mott will continue in his role.","No change in John T. Treace's compensation in connection with appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-051362","json":"https://secwatch.observer/filing/0000950170-25-051362.json","markdown":"https://secwatch.observer/filing/0000950170-25-051362.md","text":"https://secwatch.observer/filing/0000950170-25-051362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/tmci-20250407.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T19:42:54.834817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"33f08d1d48","claim":"John T. Treace was appointed as Chairman of the Board at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"89648a5d5c","claim":"James T. Treace retired as Director at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}